Novant Health Cancer Institute - Statesville

Clinical research site in Stateville, North Carolina

Part of Novant Health Cancer Institute

As of July 2026, 2 paid clinical trials are recruiting at Novant Health Cancer Institute - Statesville in Stateville, North Carolina. Active studies at this site cover conditions such as Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma and Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Novant Health Cancer Institute - Statesville (2)

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for Anaplastic Large Cell Lymphoma, ALK-Negative

137 locations incl. Birmingham

Sponsor: Eastern Cooperative Oncology Group

Sex: All·Age: 18 - 75

Code: NCT06724237·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for Lymphoma

44 locations incl. Tuscaloosa

Sponsor: University of Rochester

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05006482·Phase 3·Recruiting·Listed Aug 2021

Apply to this trial

Explore more

Paid clinical trials in Stateville, NC · North Carolina clinical trials